Flash Finance

Remedium Life539561Corporate

Trading & Distributors Latest results: Sep 2025 3 quarters of data
Consolidated Standalone
₹0.26
MCap ₹23 Cr · P/E 2.0
Remedium Life — Stock analysis & AI research Remedium Life — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹111 Cr
Sales · Sep 2025
₹7 Cr
Operating Profit · Sep 2025
6.6%
OPM % · Sep 2025
₹9 Cr
Net Profit · Sep 2025
₹0.10
EPS · Sep 2025

📝 Remedium Life — results explained

Quarter ended September 2025 (Q2 FY26)

Remedium Life reported revenue of ₹111 crore for the quarter ended September 2025 (Q2 FY26), and down 2.0% sequentially over the June 2025 quarter.

Net profit stood at ₹9 crore. Earnings per share (EPS) came in at ₹0.10.

Operating profit stood at ₹7 crore — an operating margin (OPM) of 6.6%.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹489 crore with a net profit of ₹11 crore.

Valuation snapshot

At the current price of ₹0.26, 539561 has a market capitalisation of ₹23 crore and a trailing P/E of about 2.0.

Within the Trading & Distributors industry, it is the 25th-largest of the 178 companies we track by market value.

Shareholding pattern

As of Dec 2025, promoters held 1.13%, foreign institutional investors (FIIs) 1.70%, public shareholders 97.17% of Remedium Life.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹23 Cr
Current Price ?
₹0.3
P/E ?
2.04below ind
Industry P/E ?
22.40
P/B ?
0.22
P/S ?
0.05
P/FCF ?
-0.02
Enterprise Value ?
₹1,111 Cr
EV/EBITDA ?
126.38
PEG ?
N/A
Earnings Yield ?
0.8%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹489 Cr
OPM ?
1.8%
Profit after tax (TTM) ?
₹11 Cr
EPS (TTM) ?
₹0.13
ROCE ?
N/A
ROE ?
10.7%
ROA ?
0.7%
Growth
Sales — latest qtr ?
₹111 Cr
PAT — latest qtr ?
₹9 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹1,088 Cr
Debt to Equity ?
10.36
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
1.13%
Change in promoter holding ?
0.02%
Pledged percentage ?
N/A
Market
Return 3 months ?
-7.1%
Return 6 months ?
-29.7%

🗓️ Quarterly results (3 quarters · ₹ Cr)

same fiscal quarter as Sep bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2025Jun 2025Sep 2025 YoY % QoQ %
Sales 264113111 — -2.0%
Operating Profit -027 — +294.7%
Other Income 133 — -6.6%
Interest 2-00 — +152.8%
Depreciation 000 — —
Profit Before Tax -1610 — +82.8%
Net Profit -259 — +85.4%
EPS -0.020.050.10 — +100.0%
OPM % -0.2% 1.6% 6.6% — +312.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 2 periods)

Metric Mar 2025Sep 2025 % Chg
Equity Capital 4088 +120.0%
Reserves 417 +325.0%
Borrowings 1,1411,088 -4.6%
Other Liabilities 535430 -19.6%
Total Liabilities 1,7201,623 -5.6%
Fixed Assets 06 —
CWIP 00 —
Investments 00 —
Other Assets 1,7201,617 -6.0%
Total Assets 1,7201,623 -5.6%

💧 Cash Flow (latest 1 periods)

Metric Mar 2025 % Chg
Cash from Operating Activity -1,135 —
Cash from Investing Activity 0 —
Cash from Financing Activity 1,136 —
Net Cash Flow 1 —
Free Cash Flow -1,135 —
CFO/OP -90,064% —

➗ Ratios (latest 1 periods)

Metric Mar 2025 % Chg
Debtor Days 695 —
Inventory Days 247 —
Days Payable 459 —
Cash Conversion Cycle 483 —
Working Capital Days 38 —

👥 Shareholding (latest 4 periods)

Metric Mar 2025Jun 2025Sep 2025Dec 2025 % Chg
Promoters 1.11%1.13%1.13%1.13% +0.0%
FIIs 0.00%0.00%0.00%1.70% —
Public 98.89%98.87%98.87%97.17% -1.7%
No. of Shareholders 1,10,4221,13,5431,14,1191,11,269 -2.5%

⚖️ Peer comparison

Industry: Trading & Distributors · top 25 of 178 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 MMTC MMTC ₹56.85 8,527 19.1 3 448 -5900.3% 14818.2% 11.3% 345.1% -32.0% 136.9%
2 MSTCLTD Mstc ₹717.80 5,053 21.6 386 234 60.5% 60.6% 13.1% -50.9% 22.4% 37.5%
3 526125 BN Agrochem ₹273.00 1,960 156.9 928 17 -0.5% 1.8% 191.7% 57.2% 26.7% -85.2%
4 CNL Creative Newtech ₹1,065.50 1,600 23.6 2,784 74 3.6% 2.6% 52.1% 31.8% 21.1% 32.9%
5 512038 TCC Concept ₹273.00 949 20.0 285 68 43.9% 23.7% 115.7% 56.1% 483.1% 40.5%
6 530929 RRP Defense ₹16.11 861 — 12 -1 -8.5% -8.3% 18.6% -190.4% 32.0% -354.4%
7 540980 Yamuna Syndicate ₹54,250.00 799 18.3 73 91 2.4% 125.6% 7.8% -4.3% 18.6% -78.9%
8 SHIVAUM Shiv Aum ₹551.40 750 66.1 672 11 3.2% 1.7% — — 22.5% 128.6%
9 538563 538563 — 661 — 166 24 26.3% 14.3% 710.0% 1000.0% 14.6% 90.3%
10 STCINDIA State Trading ₹104.37 626 1.0 — 639 — — — 2410.5% — -71.1%
11 524723 Arvaya Healthcare ₹23.00 557 — 0 -2 -2043.5% -1985.7% -100.0% -1138.5% — -254.3%
12 ROCKINGDCE Rockingdeals Cir ₹642.35 533 54.5 120 10 13.9% 8.4% — — 91.2% 150.0%
13 524480 Riddhi Siddhi ₹640.85 514 — 171 -17 -8.6% -9.9% 74.8% 0.0% -42.0% -62.4%
14 531191 Filtron Engineers ₹7.00 465 235.0 — 0 — — -100.0% 166.7% — 4800.0%
15 OSWALAGRO Oswal Agro ₹33.97 457 — 19 -23 7.0% -118.5% -88.1% -120.2% -100.0% -172.9%
16 512229 Veritas (India) ₹1,036.00 437 — 3,424 -0 2.0% -0.0% -24.1% -82.5% 52.9% -84.8%
17 539834 Balgopal Commercial ₹39.87 393 — — -5 — — — -214.3% — 157.3%
18 KOTHARIPRO Kothari Products ₹63.50 379 19.5 1,031 19 -6.0% 1.9% 5.4% 135.3% 8.6% -64.7%
19 540829 540829 — 347 — 74 2 6.0% 3.4% — — -83.8% -88.2%
20 539922 Rotographics (India) ₹45.01 330 53.0 45 1 0.1% 2.5% 4987.7% 616.7% 37.7% 127.0%
21 538537 538537 — 323 — — -2 — — — -935.0% — -3700.0%
22 512026 Vega Jewellers ₹2.04 315 0.2 978 47 8.9% 4.8% — — — —
23 540717 Polo Queen ₹43.72 296 n/m 76 3 5.6% 3.4% -5.7% -2.7% 49.8% -46.0%
24 SAKUMA Sakuma Exports ₹1.50 235 19.8 1,666 11 0.3% 0.6% -25.4% -35.7% -11.3% 70.5%
25 539561 Remedium Life ₹15.99 23 — 147 -2 -9.4% -1.5% -94.5% -60.3% -65.8% -96.1%
❓ Frequently asked questions
What was Remedium Life's revenue in Q2 FY26?
Remedium Life reported revenue of ₹111 crore for the quarter ended September 2025 (Q2 FY26), and down 2.0% sequentially over the June 2025 quarter.
What was Remedium Life's net profit in Q2 FY26?
Net profit stood at ₹9 crore. Earnings per share (EPS) came in at ₹0.10.
What is 539561's market capitalisation and P/E ratio?
At the current price of ₹0.26, 539561 has a market capitalisation of ₹23 crore and a trailing P/E of about 2.0.
Who owns Remedium Life? (shareholding pattern)
As of Dec 2025, promoters held 1.13%, foreign institutional investors (FIIs) 1.70%, public shareholders 97.17% of Remedium Life.
TTM ends 2025-09-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI